Chemotherapy Treatment Considerations in Metastatic Breast Cancer

Area of Science:

• Oncology
• Medical Chemistry

Background:

• Metastatic breast cancer (MBC) historically treated with surgery and chemotherapy.
• Advancements in molecular understanding have yielded targeted therapies.
• Chemotherapy remains a cornerstone for managing metastatic disease, controlling spread, and palliative care.

Purpose of the Study:

• To highlight the continued importance of chemotherapy in MBC treatment.
• To underscore the need for personalized chemotherapy sequencing.
• To identify strategies for reducing treatment toxicities and enhancing patient outcomes.

Main Methods:

• Review of current chemotherapy agents and targeted therapies for MBC.
• Analysis of ongoing investigations into combination therapies.
• Exploration of molecular underpinnings for personalized treatment approaches.

Main Results:

• Chemotherapy agents are integral to current and future MBC treatment paradigms.
• Combinations of targeted agents and chemotherapy are under active investigation.
• Individualized treatment strategies are essential for optimizing MBC care.

Conclusions:

• Chemotherapeutic agents will remain central to metastatic breast cancer therapy.
• Personalizing chemotherapy sequencing based on patient profiles is a critical unmet need.
• Optimizing treatment selection can reduce toxicity and improve patient outcomes in MBC.